BioMarin Pharmaceutical Inc. (BMRN) Reports Q1 Loss of $0.04
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.67 +2.82%
Revenue Growth %: +32.7%
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +32.7%
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $109.46 million versus the consensus estimate of $103.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $90; Piper Sandler: 'Remain Buyers'
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $60 at H.C. Wainwright
- Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
